Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid (Q44478693)

3 December 2017

Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid (English)

1 reference

3 December 2017

hepatocellular carcinoma

1 reference

4

1 reference

3 December 2017

Rie Matsushima-Nishiwaki

1

1 reference

3 December 2017

Masataka Okuno

2

1 reference

3 December 2017

Yukihiko Takano

3

1 reference

3 December 2017

Scott L Friedman

5

1 reference

3 December 2017

Hisataka Moriwaki

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

22 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

24

1 reference

3 December 2017

8

1 reference

3 December 2017

1353-1359

1 reference

Retinoids in chemoprevention and differentiation therapy

3 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

The promise of retinoids to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Aberrant metabolism of retinoid X receptor proteins in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Retinoid agonist activities of synthetic geranyl geranoic acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Regulation of retinoic acid receptor alpha by protein kinase C in B16 mouse melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Interdomain communication regulating ligand binding by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGG090

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGG090

1 reference

3 December 2017

1 reference